Zobrazeno 1 - 10
of 47
pro vyhledávání: '"James W. Baker"'
Autor:
Timothy Craig D.O., Ralph Shapiro M.D., Arthur Vegh M.D., James W. Baker M.D., Jonathan A. Bernstein M.D., Paula Busse M.D., Markus Magerl M.D., Inmaculada Martinez-Saguer M.D., Marc A. Riedl M.D., William Lumry M.D., Debora Williams-Herman M.D., Jonathan Edelman M.D., Henrike Feuersenger Ph.D., Thomas Machnig M.D., Mikhail Rojavin Ph.D.
Publikováno v:
Allergy & Rhinology, Vol 8 (2017)
Background The plasma-derived, pasteurized, nanofiltered C1-inhibitor concentrate (pnfC1-INH) is approved in the United States as an intravenous (IV) on-demand treatment for hereditary angioedema (HAE) attacks, and, in Europe, as on demand and short-
Externí odkaz:
https://doaj.org/article/37417623447f45af92b3c0e6ec303117
Publikováno v:
Allergy and Asthma Proceedings. 39:359-364
Background Hereditary angioedema (HAE) may occur at or spread to multiple anatomic locations during an acute attack. Recombinant human C1 esterase inhibitor (rhC1-INH) is approved for treating acute HAE attacks. Objective To examine the time to the b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e49f286f0fc4576939d66835c53afb1
https://doi.org/10.2500/aap.2018.39.4151
https://doi.org/10.2500/aap.2018.39.4151
Autor:
Unnur S Bjornsdottir, Stephen T Holgate, Padmalatha S Reddy, Andrew A Hill, Charlotte M McKee, Cristina I Csimma, Amy A Weaver, Holly M Legault, Clayton G Small, Renee C Ramsey, Debra K Ellis, Conor M Burke, Philip J Thompson, Peter H Howarth, Andrew J Wardlaw, Phillip G Bardin, David I Bernstein, Louis B Irving, Geoffrey L Chupp, George W Bensch, Gregory W Bensch, Jon E Stahlman, Monroe Karetzky, James W Baker, Rachel L Miller, Brad H Goodman, Donald G Raible, Samuel J Goldman, Douglas K Miller, John L Ryan, Andrew J Dorner, Frederick W Immermann, Margot O'Toole
Publikováno v:
PLoS ONE, Vol 6, Iss 7, p e21902 (2011)
Asthma exacerbations remain a major unmet clinical need. The difficulty in obtaining airway tissue and bronchoalveolar lavage samples during exacerbations has greatly hampered study of naturally occurring exacerbations. This study was conducted to de
Externí odkaz:
https://doaj.org/article/f4ed057e1067408a9023f1d201f1a2b4
Autor:
Henrike Feuersenger, Timothy J. Craig, Jonathan A. Bernstein, Mikhail Rojavin, Debora Williams-Herman, Inmaculada Martinez-Saguer, William R. Lumry, Ralph Shapiro, Jeffrey Rosch, Marc A. Riedl, James W. Baker, Jonathan M. Edelman, Paula J. Busse, Michael M. Frank, Markus Magerl
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 5:1142-1145
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57b319f8e9a06aaca2473cd1b7915ba7
https://doi.org/10.1016/j.jaip.2016.12.033
https://doi.org/10.1016/j.jaip.2016.12.033
Autor:
Jagvendra Meena, Melinda Soffer, Timothy Craig, Prasanna Nagarhalli, Sourav Chowdhury, Sangeet Kapoor, Nancy J. Sherman, Stephen Andersen, James W. Baker, Kristen Taddonio, Lindsey Leitzel
Publikováno v:
SAE Technical Paper Series.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79a09c7e7dc356000283bcabb86472df
https://doi.org/10.4271/2018-37-0030
https://doi.org/10.4271/2018-37-0030
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0194236 (2018)
PLoS ONE
PLoS ONE
Background A continuous subcutaneous infusion (CSCI) is an effective method of multiple drug administration commonly encountered in end of life care when the oral route is compromised. At present, current practice is to limit syringe driver infusion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8347bdc0dab1f38d91c575df01f5d1d3
http://europepmc.org/articles/PMC5851608?pdf=render
http://europepmc.org/articles/PMC5851608?pdf=render
Publikováno v:
Allergy and asthma proceedings. 38(6)
BACKGROUND Severe attacks of hereditary angioedema (HAE) are debilitating and potentially life threatening, and can increase anxiety and the use of medical resources. OBJECTIVE This post hoc assessment evaluated recombinant human C1 esterase inhibito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::012181daa74007534505c124846fd2a2
https://pubmed.ncbi.nlm.nih.gov/28874235
https://pubmed.ncbi.nlm.nih.gov/28874235
Autor:
Timothy Craig, James W. Baker, Prasanna Nagarhalli, Sangeet Kapoor, Sourav Chowdhury, Lindsey Leitzel, Jagvendra Meena, Stephen Andersen, Melinda Soffer
Publikováno v:
SAE Technical Paper Series.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db9fd3d74e3394d2b4254b77b662fa08
https://doi.org/10.4271/2017-01-0173
https://doi.org/10.4271/2017-01-0173
Autor:
James W. Baker, Arthur B. Vegh, Marc A. Riedl, William R. Lumry, Thomas Machnig, Jonathan A. Bernstein, Inmaculada Martinez-Saguer, Timothy J. Craig, Mikhail Rojavin, Markus Magerl, Henrike Feuersenger, Ralph Shapiro, Debora Williams-Herman, Jonathan M. Edelman, Paula J. Busse
Publikováno v:
Allergy & Rhinology, Vol 8 (2017)
Allergy & Rhinology
Allergy & Rhinology
Background: The plasma-derived, pasteurized, nanofiltered C1-inhibitor concentrate (pnfC1-INH) is approved in the United States as an intravenous (IV) on-demand treatment for hereditary angioedema (HAE) attacks, and, in Europe, as on demand and short
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8091c9bb33293398f7a617b75c878c8e
https://doaj.org/article/37417623447f45af92b3c0e6ec303117
https://doaj.org/article/37417623447f45af92b3c0e6ec303117
Autor:
Ryan Iarrobino, Joseph C. Biedenkapp, Burt Adelman, Chris Stevens, Jon A. Kenniston, Aleena Banerji, Marc A. Riedl, Christopher Tenhoor, H. Henry Li, Timothy J. Craig, James W. Baker, Carolyn Soo, Mark Davis-Lorton, Ryan Faucette, Richard F. Lockey, Henry J. Wedner, Marco Cicardi, Jonathan A. Bernstein, Mustafa Shennak, J. Gordon Still, Paula J. Busse, William R. Lumry, Joshua J. Jacobs, Harvey Kushner, Yung Chyung, Daniel J. Sexton, Ahmad Al-Ghazawi, Robert Mensah
Publikováno v:
The New England journal of medicine. 376(8)
Hereditary angioedema with C1 inhibitor deficiency is characterized by recurrent, unpredictable swelling episodes caused by uncontrolled plasma kallikrein generation and excessive bradykinin release resulting from cleavage of high-molecular-weight ki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e21a724d42f89faa2f1a540689fc0c2a
https://pubmed.ncbi.nlm.nih.gov/28608074
https://pubmed.ncbi.nlm.nih.gov/28608074